Daily Stock List
Diversified Resources, Inc. (DDRI)
SmallCapVoice reported on Diversified Resources, Inc. (DDRI), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Diversified Resources, Inc. centers on independent oil and gas exploration and production. It has operations in the Denver-Julesberg Basin and Raton Basins in Colorado and the San Juan Basin of New Mexico. In November of 2013, Natural Resource Group, Inc. merged into Diversified Resources, Inc. and became a publically trading company on the OTCQB. Diversified Resources is based in Littleton, Colorado.
The Company’s near term focus is to identify and develop a balanced portfolio of low risk, high return drilling prospects that include conventional and unconventional sites targeting different oil horizons and low risk, conventional offsets to existing production.
Diversified Resources purchased BIYA Operators, Inc. in October of 2014. It then established New Mexico operations in the Horseshoe Gallup. Currently, Diversified Resources is producing roughly 85 bbls of oil per day with 55 additional locations to drill in the San Juan Basin and 16 wells to drill in the Denver-Julesberg Basin.
In the Denver-Julesberg Basin, Colorado, the Company’s strategy is to acquire acreage and production capable of growing cash flow and reserves. It uses its expertise in geology and geophysical evaluation to ascertain favorable drill-site lease acquisition regions. It acquired the 640 acre “Timm Lease”. Its plan is to drill, vertically, one vertical well and subsequently commence a horizontal drilling program. The lease is prospective for oil and gas in the “J-Sand”, Codell, Niobrara and Hygiene formations.
Diversified Resources acquired approximately 4,600 acres in the Garcia Field in 2011. The Garcia Field is situated in the Colorado portion of the Raton Basin. The Company states that it considers the field to be a significant factor in its plan for growth. It owns 100 percent (80 percent NRI) of 5,241 mineral acres in the field, the majority of which is held by production.
Regarding the San Juan Basin, Colorado, Diversified Resources closed on the purchase of BIYA Operators giving it a 100 percent interest in about 10,400 acres in the aforementioned Horseshoe Gallup Field in the San Juan Basin. It also acquired interest in 48 producing wells, associated production equipment, and dozens of potential vertical and horizontal drilling locations.
Diversified Resources entered into an Agreement to Exchange Securities of Diversified Energy Services, Inc. (DESI) a Colorado based company, on February 5, 2016. DESI now operates as a wholly-owned subsidiary of Diversified Resources. DESI offers Crane Service, Well Site Construction, Materials Handling and Disposal, Trucking Services, Equipment Operation, and Rigging to the energy industry in the Denver Julesburg Basin and the Rockies.
Diversified Resources has strong production from reworks of existing properties; cost advantages from the integration of services; and a service business EBITDA of $3.1M, as well as a projected annual EBITDA increase of 5 percent for the next 3 years.
Diversified Resources, Inc. (DDRI), closed Thursday's trading session at $0.31, even for the day. The average volume for the last 60 days is 2,644 and the stock's 52-week low/high is $0.2216/$0.50.
Solar Alliance Energy, Inc. (SAENF)
We are reporting on Solar Alliance Energy, Inc. (SAENF) today, here at the QualityStocks Daily Newsletter.
Solar Alliance Energy, Inc. is a solar sales and marketing organization headquartered in Vancouver, British Columbia. The Company concentrates on residential solar installations. Since its establishment in 2003, Solar Alliance has developed more than 360 megawatts of renewable energy projects and then sold them to utilities or large independent power producers. Moreover, it has installed in excess of 2,000 residential solar systems in southern California. Solar Alliance Energy’s shares trade on the OTCQB.
The Company provides everything one requires to get solar installed at their home and start producing cost effective, clean electricity. Solar Alliance Energy will come to one’s home and walk them through all the options, free of charge. Its certified sales professionals will analyze and discuss one’s electricity usage, take a look at their rooftop using digital imaging, and also provide a customized solar solution for their home.
Solar Alliance Energy then designs a custom solar system. Subsequently, the Company send its installation team to conduct a professional site survey at one’s home. This involves taking precise measurements and measuring the condition of one’s roof and electric panel.
Last month, Solar Alliance Energy announced it signed an agreement with the Marine Corps Community Services (MCCS) at Camp Pendleton in San Diego, California to market residential solar systems to active duty, retired, and also civilian employees. The contract permits Solar Alliance to market to greater than 70,000 daily visitors to Camp Pendleton, which is the largest Marine Corps base in the world.
In addition, in July, Solar Alliance Energy announced the launch of a Commercial Solar Division. The Commercial Solar Division will be headquartered in San Diego, California. It will target commercial and industrial customers across the U.S.
Solar Alliance Energy Chairman and Chief Executive Officer, Mr. Jason Bak, said in July, "The launch of a Commercial Solar Division marks the next stage of our Company's development in solar energy and will provide another revenue stream for Solar Alliance."
Regarding commercial installations, the Company will develop a custom proposal for a business. Moreover, it will provide a business with a single point of contact who will ensure safe, on time, and on budget installation. The emphasis of the Solar Alliance Energy commercial team is to help a business save money on electricity.
Solar Alliance Energy, Inc. (SAENF), closed Thursday's trading session at $0.06, even for the day. The average volume for the last 60 days is 10,730 and the stock's 52-week low/high is $0.031/$0.084.
OriginClear, Inc. (OCLN)
Today we are reporting on OriginClear, Inc. (OCLN), here at the QualityStocks Daily Newsletter.
OTCQB-listed OriginClear, Inc. is a foremost provider of water treatment solutions. In addition, the Company is the developer of a pioneering water cleanup technology. By way of its wholly-owned subsidiaries, OriginClear provides systems and services to treat water in a broad spectrum of industries. These include municipal, pharmaceutical, semiconductors, industrial, and oil & gas. OriginClear is headquartered in Los Angeles, California.
OriginClear invented Electro Water Separation™. This is a pioneering high-speed water cleanup technology employing multi-stage electrolysis, which the Company licenses globally to water treatment equipment manufacturers. Electro Water Separation™ (EWS) is a highly scalable, continuous process. It uses electricity in small, programmed doses to gather up oils and suspended solids. Moreover, via Advanced Oxidation or AOx, it removes fine, micron-sized suspended solids, and dissolved contaminants, including ammonia.
Last year, OriginClear launched a subsidiary in Hong Kong named OriginClear (HK). It granted OriginClear (HK) a master license for China. In turn, the subsidiary is expected to license regional joint ventures (JVs) for frack and waste water treatment. In addition, a research and a manufacturing center are planned.
OriginClear (HK) manages Asian and Oceanian market development and also OriginClear Technologies’ Manufacturing arm. The technology team is an internal division together with the OriginClear Group. OriginClear also has its wholly-owned subsidiary, Progressive Water Treatment (PWT) of Dallas, Texas.
OriginClear’s corporate mission is to develop Electro Water Separation™ with Advanced Oxidation™ (EWS:AOx™) and attain its full recognition as a global industry standard in treating increasingly complex wastewater treatment challenges. OriginClear Technologies relies on a continuing strong research and development (R&D) and engineering activity for the development of its technology. This is while actively building its licensees, JVs and partners network for commercial development.
Yesterday, OriginClear announced that its Q2 10-Q filing revealed that, for the six months ended June 30, 2016, revenues grew 2,323 percent, and gross profit by 1,853 percent, over the six months ended 2015. Revenues were $3,165,180, versus $136,280 for the six months ended June 30, 2015. Gross Profit was $967,057 for the six months ended June 30, 2016 versus $49,986 for the six months ended June 30, 2015. The growth of Progressive Water Treatment (PWT), powered this upsurge in revenue.
OriginClear, Inc. (OCLN), closed Thursday's trading session at $0.103, up 1.56%, on 3,229,063 volume with 117 trades. The average volume for the last 60 days is 1,126,429 and the stock's 52-week low/high is $0.008/$0.02.
Globalink Ltd. (GOBK)
Winston Small Cap, Elite Stock Alerts, Journal Transcript, StockHideout, OTCMagic, MicroCapDaily, SmallCap Network, StockMister, 1-2-3 Stock Alerts, PennyPickAlerts, and Fortune Stock Alerts reported on Globalink Ltd. (GOBK), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Globalink Ltd., by way of its subsidiary, OneWorld Hotel Destination Service, Inc., provides Internet hotel booking services. The Company mainly serves travel agents in Vancouver, British Columbia; Toronto, Ontario: Calgary, Alberta; as well as Montreal, Quebec. Established in 2006, Globalink has its corporate head office in Vancouver. A Nevada Company, its shares trade on the OTC Markets Group’s OTCQB.
Globalink provides a proprietary online hotel booking program. This program is for connecting users with available rooms in hotels around the world. In addition, Globalink has a gingko plantation and a health nutrition product business under development in Jiangsu Province, China.
In 2014, Globalink added some new Chinese investors. These investors brought their knowledge, experience, wide-ranging connections and business opportunities in both China and North America. At present, Globalink is centering on developing a ginkgo plantation and carrying related research and development (R&D) in China.
In 2014, Globalink entered into a Joint Venture (JV) agreement with Shizheng Bio-Technology Co., Ltd. in Jiangsu Province, China. Additionally, in 2014, Gloablink (Xuzhou) Bio-Technology Co., Ltd. was incorporated in Pizhou City, Jiangsu Province, China pursuant to the JV agreement.
Globalink Xuzhou will engage in biological sciences and technology popularization services, as well as fruit and vegetable distribution. Last year, Gloablink Xuzhou began to develop a ginkgo plantation in Pizhou City, the area which provides approximately 70 percent of the ginkgo leave supply in China.
Last October, Globalink incorporated a wholly-owned subsidiary, Globalink (Zhejiang) Bio-Technology Co., Ltd. in Ningbo City, Jiangsu Province, China. Globalink Zhejiang will engage in the research, development, cultivation, extraction, and application of ginkgo trees and other economic plants.
Globalink Zhejiang entered into a Technology Development Service Agreement in January of this year with Zhejiang Pharmaceutical College. This Agreement has a term of three years. With this development agreement, the College will conduct R&D on induction of callus of ginkgo leaves and extraction, and the identification of flavone and lactone there from. The success of the project will considerably increase the production of ginkgo leaves and the effective ingredients contained in them.
Globalink states that its solid base of strategic plans for travel and health based products is complemented by development and exploration projects and continued evaluation of accretive acquisition opportunities.
Globalink Ltd. (GOBK), closed Thursday's trading session at $0.012, down 20.00%, on 116,727 volume with 11 trades. The average volume for the last 60 days is 114,887 and the stock's 52-week low/high is $0.0041/$0.10.
Boston Therapeutics, Inc. (BTHE)
RedChip, TaglichBrothers, Stock News Now, TopPennyStockMovers, SmallCapVoice, and PennyStocks24 reported on Boston Therapeutics, Inc. (BTHE), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Boston Therapeutics, Inc. is a developer of complex carbohydrate therapeutics to treat diabetes and inflammatory diseases. Its product pipeline focuses on developing and commercializing therapeutic molecules, which address diabetes and inflammatory diseases. Additionally, the Company developed and markets SUGARDOWN®. This is a non-systemic, complex carbohydrate-based dietary food supplement. The design of SUGARDOWN® is to support healthy blood glucose. Boston Therapeutics has its corporate headquarters in Newton, Massachusetts.
Its product pipeline includes BTI-320. This is a non-systemic, non-toxic, chewable complex carbohydrate-based compound. The design of it is to decrease post-meal glucose elevation. BTI-320 is a proprietary polysaccharide. It is to be taken before meals. BTI-320 works in the gastrointestinal tract to block the action of carbohydrate-hydrolyzing enzymes that break down complex carbohydrates into simple sugars, decreasing the availability of glucose for absorption into the bloodstream.
The Company entered into a clinical trial agreement with Joslin Diabetes Center to be the lead clinic in a Phase II study of BTI-320. Furthermore, Boston Therapeutics’ product pipeline includes IPOXYN™. This is an injectable anti-necrosis drug. The design of it initially is to treat lower limb ischemia associated with diabetes. IPOXYN™ comprises a stabilized glycoprotein composition containing oxygen-rechargeable iron, targeting human and animal tissues and organ systems deprived of oxygen and in need of metabolic support.
In 2015, Boston Therapeutics announced that its affiliate, Advance Pharmaceutical, initiated the SUGARDOWN® clinical trial in Hong Kong. Advance Pharmaceutical is evaluating the effect of SUGARDOWN® on Post-Prandial Hyperglycemia in Chinese subjects with Pre-Diabetes. The lead clinical site is the Department of Medicine, The Chinese University of Hong Kong (CUHK), Prince of Wales Hospital.
Advance Pharmaceutical is conducting the above-mentioned clinical trial at The Chinese University of Hong Kong (CUHK) to evaluate BTI-320 in subjects who are pre-diabetic. The interim clinical analysis in the proof of concept trial demonstrate up to 77 percent reduction in Glucose and up to 27 percent in Fructose.
Boston Therapeutics released (last December) final trial results from its proof of concept (POC) Sydney University study. The study showed consumption of SUGARDOWN® tablets before sugary beverages was found to significantly lessen the postprandial glucose, fructose, and insulin responses to the sugary soft drink beverage. Every subject had a favorable response.
In addition, Boston Therapeutics’ product pipeline includes OXYFEX™. This product can serve as the only available oxygen delivery mechanism for animals suffering ischemia or traumatic and surgical blood loss events. OXYFEX™ is the Company’s veterinary facsimile to IPOXYN™.
Boston Therapeutics’ technology platform in applied carbohydrate chemistry has been forged by its Chief Executive Officer, Mr. David Platt and his scientific collaborators over the last two decades.
Boston Therapeutics, Inc. (BTHE), closed Thursday's trading session at $0.0675, up 3.85%, on 35,174 volume with 11 trades. The average volume for the last 60 days is 22,675 and the stock's 52-week low/high is $0.0068/$620.00.
Monaker Group, Inc. (MKGI)
The QualityStocks Daily Newsletter would like to spotlight Monaker Group, Inc. (MKGI). Today, Monaker Group, Inc. closed trading at $3.90, up 13.04%, on 8,172 volume with 24 trades. The stock’s average daily volume over the past 60 days is 7,273, and its 52-week low/high is $1.10/$5.00.
Monaker Group, Inc. announced today that it has developed and launched a Premium Service for property owners offering participants a solution for time management and property booking optimization. Monaker's Premium Service for property owners was developed on the basis that travel industry suppliers (airlines, hotels, car rental companies) have the tools to actively manage their rates on a minute-by-minute basis allowing them to react to competitive pricing, utilization and other market conditions in efforts to maximize revenues.
Monaker Group, Inc. (MKGI) is a technology driven travel company focused on leveraging resources to become a significant presence in the fastest growing sector of the $1.3 trillion travel and tourism market. The company's flagship brand, NextTrip.com, is the industry's first and only real-time booking engine that features alternative lodging (vacation home rentals, resort residences and unused timeshare inventory), as well as a full selection of airlines, hotels, cruises, rental cars, tours and concierge services. These features are combined into a single, easy-to-use platform that gives travelers complete real-time control when planning and booking their vacations.
NextTrip.com takes an integrated approach to the needs of travelers by combining multiple booking solutions into a highly intuitive real-time booking platform. Since its launch in February 2016, NextTrip has already grown to more than 250,000 units of vacation rental inventory. Monaker currently has roughly 1 million additional alternative lodging units under contract that will soon be added to the platform. This will place NextTrip among the top three largest vacation rental inventories and rival industry peers, Airbnb and HomeAway, in the rapidly expanding alternative lodging market. Unlike the competition, which book by request which can take hours or days before a lodging owner confirms, NextTrip's platform books in real-time, similar to online hotel bookings.
Most NextTrip listings are in desirable locations in the U.S., the EU and the Caribbean with about 20% exclusive listings. Monaker expects rapid exclusive listing growth because, unlike the competition, Monaker doesn't charge a sign-up fee, just a commission upon booking. The competition charges both. Monaker even has a proprietary solution to unlock Timeshare and Fractional Share properties as rental inventory.
Through strategic partnerships and acquisitions Monaker is now positioned to be a major player in the travel and alternative lodging sector. In addition Monaker is also the parent to Maupintour and Voyage TV.
In business for 65 years, Maupintour still leads the tour industry in the creation of outstanding, unique itineraries and has the highest repeat rate in the tour industry. Maupintour's upscale luxury services create a unique blend with the various product offerings of NextTrip. Voyage TV has thousands of hours of travel footage shot in over 30 countries worldwide. These 15,000 video clips of hotels, resorts, cruise, and destination activities are a treasure trove for vacation travel marketing.
With an established portfolio of travel brands, and a proven record acquiring, consolidating and integrating companies, Monaker is building a diverse and exciting foundation to drive the company's future. According to data from the U.S. Travel Association, direct spending on leisure travel by domestic and international travelers topped $650 billion in 2015. When combined with the fact that roughly 64 percent of travel companies are still considered small businesses, Monaker's all-inclusive approach to vacation booking through NextTrip and Maupintour strategically positions it for sustainable growth moving forward.
Monaker is headquartered in South Florida with offices in California. The company is led by a seasoned management team with decades of applicable industry experience. Monaker's Chairman and Chief Executive Officer Bill Kerby has over 18 years of experience in the media and travel industries, as well as 10 years of experience in the financial industry. Disclaimer
Monaker Group, Inc. Company Blog
Monaker Group, Inc. News:
Monaker Launches Premium Service for Alternative Lodging Listings
Monaker Group Announces Agreement with Trisept Solutions
Monaker Group Files Annual Report on Form 10K for Fiscal 2016
Cherubim Interests, Inc. (CHIT)
The QualityStocks Daily Newsletter would like to spotlight Cherubim Interests, Inc. (CHIT). Today, Cherubim Interests, Inc. closed trading at $0.0167, up 145.59%, on 35,174 volume with 11 trades. The stock’s average daily volume over the past 60 days is 22,675, and its 52-week low/high is $0.0068/$620.00.
Cherubim Interests, Inc. (CHIT) is a development-stage alternative construction and real estate development company seeking various opportunities relative to the company's management team of experts in property management, construction and finance.
The company's primary focus is within the real estate development and controlled environment agriculture sectors, which Cherubim recently entered into by acquiring an exclusive worldwide license for the deployment of a proprietary plant cultivation technology. Through its wholly owned subsidiary, BudCube Cultivation Systems USA, Cherubim plans to construct, deploy and lease scalable medical and recreational marijuana cultivation facilities for commercial applications.
Coupled with a real estate development and property management business model, BudCube Cultivation Systems ("BCS") can position itself anywhere in the world where the cultivation of cannabis is legal. BCS's unique business model positions the company to greatly benefit as more market participants seek to gain entry into a fast-growing market at an attractive price point.
Armed with the ability to lease a portable and scalable turn-key cultivation solution to growers, Cherubim aims to use its licensed solution to fill the gap for both first-time and experienced cultivators who may not have the capital resources to buy land, construct or tenant-improve existing structures for the optimum environment for developing a high-quality cannabis product. Disclaimer
Cherubim Interests, Inc. Company Blog
Cherubim Interests, Inc. News:
Cherubim Interests, Inc. Signs Distribution Agreement With XWALLS Inc.
Cherubim Interests, Inc. Signs LOI to Construct Single-Family Residential Rental Properties
Cherubim Interests, Inc. Announces Letter to Shareholders
Singlepoint, Inc. (SING)
The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.0098, up 8.89%, on 1,368,765 volume with 31 trades. The stock’s average daily volume over the past 60 days is 903,342, and its 52-week low/high is $0.0041/$0.018.
Singlepoint, Inc. (SING) provides mobile technology and marketing solutions that enable companies, nonprofits and religious organizations to conduct business transactions, accept donations, and engage in targeted communication via mobile devices. Through diversification of its own model, the company is also leveraging its core technology to expand into the mobile auctions and daily fantasy sports markets.
SING currently has two fundraising solutions. Text2Bid is an interactive way to increase auction revenues. The technology makes it easy for people to bid in auctions from any text or web-enabled phone. Donate by Text allows nonprofits to securely collect one-time or recurring donations via text. This capability creates a personal experience for the donors, and enables ongoing communication between the donor and nonprofit or event sponsor.
SING's payment solutions include point-of-sale (POS) terminals, loyalty programs, payment processing, phone services and financing. Pay by Text™ enables a business to accept payment transactions and, in essence, turns the user's mobile phone into a point-of-sale device. Operating on the same platform as mobile marketing, Pay by Text is designed to increase revenues, raise the average per-transaction amount, and create a fast, easy and hassle-free method of payment.
As part of its diversification and expansion strategy, SING recently acquired an interest in DraftFury (www.draftfury.com), a company that offers skill-based NBA, NFL and MLB daily fantasy sports (DFS) contests. DraftFury is known for its innovative offerings and originality, and is the first cash-flow-positive DFS enterprise. This transaction places SING in a multi-billion dollar industry expected to generate entry fees of $14.4 billion in 2020. Under the guidance of a leadership team well-versed in technology, engineering, marketing and raising capital, SING anticipates a strong foothold in its chosen markets. Disclaimer
Singlepoint, Inc. Company Blog
Singlepoint, Inc. News:
SinglePoint, Inc. to Capitalize on the Multi-Million Dollar 'Pokemon Go' Phenomenon With Custom Mobile Application
SinglePoint, Inc. Identifies Acquisition and Funding Targets; Updates on MaloneBailey Audit Toward Uplist
A New Audio Interview with Greg Lambrecht, CEO of SinglePoint Inc., is Now at SmallCapVoice.com
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $2.00, even for the day, on 7,214 volume with 20 trades. The stock’s average daily volume over the past 60 days is 4,050, and its 52-week low/high is $1.50/$6.95.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human stem cells and the development and commercialization of cell-based biomedical products. The company was the first to develop and perfect a new class of human stem cells called parthenogenetic stem cells, created from unfertilized human eggs. ISCO has a strong patent portfolio offering clean intellectual property and freedom to operate. The company’s stem cells present superior immune matching capabilities and can be used in millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
The company’s human stem cells have been shown to be as pluripotent as embryonic stem cells, however their creation does not involve the destruction of a viable human embryo, which effectively sidesteps the controversy and ethical dilemmas associated with the use of human embryonic stem cells. In contrast to induced pluripotent stem cells, ISCO’s stem cells do not involve manipulation of cells’ genome thereby avoiding potential safety and regulatory obstacles in clinical applications.
The company's scientists are currently focused on using its stem cells to treat severe unmet medical needs of the central nervous system (Parkinson’s disease), the liver and the eye, where cell therapy has been clinically proven but is limited due to the unavailability of safe human cells. Once the technology has been clinically validated there are an essentially unlimited number of potential applications. Because of their immune-matching ability a relatively small number of these stem cell lines could offer the potential of producing the first true stem cell bank as a means of serving populations of different immune types across the globe.
In addition to its therapeutic focus, ISCO also provides a growing revenue stream through two wholly owned subsidiaries. Lifeline Cell Technology specializes in producing primary human cells and growth media for biological research, and Lifeline Skin Care, the company manufactures and markets advanced anti-aging skincare products utilizing the company’s expertise in stem cell biology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corporation Announces Operating Results for the Three and Six-Months Ended June 30, 2016
International Stem Cell Corporation Announces Successful Cell Transplantation for the First Patient in Phase 1 Clinical Trial of ISC-hpNSC
International Stem Cell Corporation Announces Publication of Preclinical Results Demonstrating Treatment of Parkinson's Disease in Cell Transplantation
The QualityStocks Daily Newsletter would like to spotlight FlexWeek (FXWK). Today, FlexWeek closed trading at $0.555, even for the day. The stock’s average daily volume over the past 60 days is 43, and its 52-week low/high is $0.075/$1.15.
FlexWeek (FXWK) is a pioneer in the global peer-to-peer (P2P) marketplace with the introduction of a unique platform that allows timeshare owners to discover, book and offer unused vacation time directly to the public and other timeshare owners. This approach eliminates the need for timeshare owners to use costly trading platforms such as Interval International or RCI, while potentially reducing unused timeshare inventory.
FlexWeek's P2P website (www.FlexWeek.com) and mobile application is similar to AirBNB's $20 billion approach to the travel industry, but is the first and only P2P marketplace exclusive to fractional vacation ownerships. FlexWeek differs from the existing model, where timeshare weeks must be "banked" with a trading company such as Interval International or RCI, and instead charges the booking fees to the renter of the vacation time, eliminating the cost to the private timeshare owner.
The FlexWeek platform also addresses another specific industry challenge. The average timeshare is only booked 79% of the year, according to the American Resort Development Association's 2012 research survey. Whether or not a privately owned timeshare unit is used, the owner still has to pay annual maintenance fees, and most owners end up losing thousands of dollars in wasted paid-for vacation time over their ownership period. With FlexWeek, an owner of unused paid vacation time can now offer their specific booked week for rent directly to the FlexWeek marketplace to recoup cost or even make a profit on the rental. The glut of unused timeshare inventory allows a potential renter to stay in a very nice condo for a fraction of what they would pay in hotel fees making it a win-win for both the owner and the renter of the vacation time.
Led by founder Kristopher Chavez, who has more than 10 years of experience operating businesses that acquire, rent, sell and transfer timeshares internationally, FlexWeek's management team will leverage its collective expertise to facilitate the company's direction and growth in this new market. FlexWeek's leadership has founded rapidly growing sales organizations generating 8-figure revenues within a year's time, and has experience scaling other models to financial success and/or acquisition rapidly with limited investment. Disclaimer
FlexWeek Company Blog
FlexWeek, Inc. (FXWK): Stay in Vacation Homes around the World for Less than the Cost of Hotels
FlexWeek, Inc. (FXWK) Announces Engagement of QualityStocks Corporate Communications Suite
FlexWeek, Inc. (FXWK) is “One to Watch”
Today's Top 3
Profitable Trader Authority
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Agora Holdings, Inc. (AGHI) Audit Is Complete, Company Continuing to Progress Its Plans to Move Up the Board to QB Level
- Alternet Systems (ALYI) Data Analytics Solution Gains Momentum with New Clients and Partners
- Cherubim Interests, Inc. (CHIT) Signs Distribution Agreement With XWALLS Inc.
- Dominovas Energy Corp. (DNRG) Open Letter to Shareholders
- eXp World Holdings, Inc. (EXPI) Reports Record Revenue and Growth for Second Quarter
- FlexWeek, Inc. (FXWK) Stay in Vacation Homes around the World for Less than the Cost of Hotels
- Giggles N' Hugs, Inc. (GIGL) engages Kiddos, Inc. and Michelle Steinberg of dOMAIN Integrated to Launch New Marketing and PR Initiatives
- International Stem Cell Corp. (ISCO) Announces Operating Results for the Three and Six-Months Ended June 30, 2016
- Laguna Blends Inc. (LAGBF) Naturally Splendid Provides Update on Laguna’s Pro369 Hemp Protein Growth and Pro Athlete Brand Strategy
- Monaker Group, Inc. (MKGI) Launches Premium Service for Alternative Lodging Listings
- Moxian, Inc. (MOXC) Adopts Oracle Database Solutions to Support the Latest Payment and Transaction Platform, Enabling Intelligent Big Data
- OurPet's Company (OPCO) Has a New Natural Solution to Your Cat Litter Woes
- Singlepoint, Inc. (SING) to Capitalize on the Multi-Million Dollar 'Pokemon Go' Phenomenon With Custom Mobile Application
- Star Mountain Resources Inc. (SMRS) Subsidiary Secures $500,000 Loan From a New York Public Benefit Trust
- WRIT Media Group, Inc. (WRIT) Announces New Funding Round